Cargando…

Clinical Features and Risk Factors of Active Tuberculosis in Patients with Behçet's Disease

To investigate the clinical features and potential risk factors of active tuberculosis (ATB) in Behçet's disease (BD), we conducted a case-control study on hospitalized BD patients in our institute from 2010 to 2019. BD patients with ATB were enrolled as the case group. The control group was se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yaxu, Zhang, Lifan, Zhou, Ziyue, Sun, Luxi, Zhou, Baotong, Liu, Xiaoqing, Zheng, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707958/ https://www.ncbi.nlm.nih.gov/pubmed/33299897 http://dx.doi.org/10.1155/2020/2528676

Ejemplares similares

1650. Clinical Features and Risk Factors of Active Tuberculosis in Patients with Behçet’s Disease
por: Liu, Yaxu, et al.
Publicado: (2020)

The Clinical Features, Risk Factors, and Outcome of Aneurysmal Lesions in Behcet's Disease
por: Zhou, Jiaxin, et al.
Publicado: (2019)

Analysis of Factors Influencing Diagnostic Accuracy of T-SPOT.TB for Active Tuberculosis in Clinical Practice
por: Zhang, Lifan, et al.
Publicado: (2017)

Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet’s disease
por: Wu, Xiuhua, et al.
Publicado: (2019)

Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study
por: Zhang, Lifan, et al.
Publicado: (2021)

The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet's Disease
por: Yan, Dong, et al.
Publicado: (2019)

Effectiveness and safety of low-dose interferon alpha-2a treatment in Behçet’s Syndrome with refractory vascular or neurological involvement: a case series
por: Sun, Luxi, et al.
Publicado: (2022)

Utility of T-Cell Interferon-γ Release Assays for Etiological Diagnosis of Classic Fever of Unknown Origin in a High Tuberculosis Endemic Area — a pilot prospective cohort
por: Shi, Xiaochun, et al.
Publicado: (2016)

Neutrophil Extracellular Traps Promote Aberrant Macrophages Activation in Behçet’s Disease
por: Li, Lu, et al.
Publicado: (2021)

Cytomegalovirus antigen-specific T cell immune responses in patients with autoimmune diseases under different cytomegalovirus infection status
por: Tan, Yuting, et al.
Publicado: (2023)

Perioperative management with biologics on severe aortic valve regurgitation caused by Behçet syndrome: the experience from a single center
por: Sun, Luxi, et al.
Publicado: (2021)

Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection
por: Zhang, Lifan, et al.
Publicado: (2022)

The Clinical Feature of Behçet's Disease in Northeastern China
por: Shang, Yingbin, et al.
Publicado: (2009)

Clinical Features and Risk Factors for Active Tuberculosis in Takayasu Arteritis: A Single-Center Case-Control Study
por: Zhou, Jiawei, et al.
Publicado: (2021)

Incidence and risk factors of tuberculosis in systemic lupus erythematosus patients: a multi-center prospective cohort study
por: Zhang, Lifan, et al.
Publicado: (2023)

Effects of breast milk on Behçet’s disease clinical features
por: KONAK, Hatice Ecem, et al.
Publicado: (2023)

Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study
por: Zhang, Lifan, et al.
Publicado: (2017)

Risk factors of cardiovascular involvement in patients with Behcet's disease
por: Wang, Yuqian, et al.
Publicado: (2023)

Metabolomic alterations associated with Behçet’s disease
por: Zheng, Wenjie, et al.
Publicado: (2018)

Behçet’s Disease and Tuberculosis: A Complex Relationship
por: Freitas, Sara Mendonça, et al.
Publicado: (2020)

Behçet’s disease with latent Mycobacterium tuberculosis infection
por: Shen, Yan, et al.
Publicado: (2020)

The diagnosis of Adamantiades-Behçet disease: Clinical features and diagnostic/classification criteria
por: Bergamo, Serena
Publicado: (2022)

Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behçet’s uveitis
por: Shi, Jing, et al.
Publicado: (2019)

Pathologic Features of Behçet's Disease in the Tubuler Gut
por: Kara, Tuba, et al.
Publicado: (2012)

PW03-014 - TLR4 and MEFV variants are Behçet's risk factors
por: Kirino, Y, et al.
Publicado: (2013)

Fall Risk in Patient with Behcet’s Disease and Related Factors
por: Uzkeser, Hülya, et al.
Publicado: (2022)

Behçet's Disease Complicated with Thrombosis: A Report of 93 Chinese Cases
por: Wu, Xiuhua, et al.
Publicado: (2014)

60 Childhood Behçet disease: clinical features, management and outcome of 13 cases
por: El Qadiry, R, et al.
Publicado: (2022)

652. Comparison of QuantiFERON-TB Gold Plus and T-SPOT.TB in the Diagnosis of Active Tuberculosis
por: Zhang, Lifan, et al.
Publicado: (2021)

Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China
por: Liu, Xiaoqing, et al.
Publicado: (2021)

Epidemiologic and Etiological Features of Korean Patients With Behçet’s Disease
por: Choi, Soo Hyun, et al.
Publicado: (2021)

It’s Not Behçet’s!
por: Liu, Yen Chen, et al.
Publicado: (2010)

Critical Role of Gut Microbiota and Epigenetic Factors in the Pathogenesis of Behçet’s Disease
por: Ma, Xiaomin, et al.
Publicado: (2021)

Clinical Features and Outcomes of Spinal Tuberculosis in Central China
por: Tang, Lei, et al.
Publicado: (2022)

Behçet's Disease (Adamantiades-Behçet's Disease)
por: Kaneko, Fumio, et al.
Publicado: (2011)

Comparison of diagnostic accuracy of QuantiFERON‐TB Gold Plus and T‐SPOT.TB in the diagnosis of active tuberculosis in febrile patients
por: Zhang, Lifan, et al.
Publicado: (2022)

Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet’s Disease in Actual Clinical Practice
por: Kim, Bun, et al.
Publicado: (2015)

Immunopathogenesis of Behcet's Disease
por: Tong, Bainan, et al.
Publicado: (2019)

Neuro-Behcet disease
por: Zhang, Lin, et al.
Publicado: (2021)

Pharmacotherapy for Behçet’s Disease and the Risk of Malignancy
por: Huang, Mao-Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_98gtnkrmft1ocu04v3mhjuejvv